KING OF PRUSSIA, PA (PRWEB) November 29, 2016
As the leader in global clinical site payments with nearly $2 billion processed to 25,000+ clinical sites in 60 countries, DrugDev knows investigator grant spend is among the top expenses in clinical trials, yet, the ability for sponsors and CROs to properly track, analyze, and forecast this spend has been severely limited. This represents a significant increase in investigator site payment requirements beyond simply transferring funds from one account to another.
Learn how to solve these issues and more at a live webinar December 1, 12- 1pm EST. BioMarin Associate Director and Head of Analytics Brenda Medina and DrugDev President, Payments Stu Thiede will share best practices to track, analyze and forecast payments in a timely and transparent way to better support the needs of clinical trial sites and investigators.
Webinar: The Evolution of Payments: It’s More Than Just a Transaction
Date: December 1, 2016
Time: 12:00-1:00 pm EST
CLICK TO REGISTER
This webinar is complimentary
Payments experts Brenda and Stu will discuss the following topics in addition to leading a Q&A session:
· Importance of data transparency and reporting
· Proper cash flow management and funding models
· Influence of US and global regulations
· Rising importance of site satisfaction
Stu Thiede explains, “Global studies are complex and present numerous challenges for the clinical operations team especially when it comes to investigator payments. In this webinar we’ll discuss how sponsors and CROs can significantly improve their game in managing country specific regulations, multiple site payees, aggregate spend reporting, VAT taxes, and cultural and language differences. The goal is to develop a payment system that keeps sites happy and engaged, expenses in line, and the study timeline on track.”
About the Speakers
Brenda Medina, BioMarin Associate Director, Head of Analytics – Brenda is a dynamic leader with an entrepreneurial mindset and a successful track record of improving clinical trial cycle times, reducing costs, and creating and implementing more efficient, higher quality processes and procedures. She is skilled at translating the clinical development process for finance teams, and financial processes for clinical teams. She develops high performing team members and creates strategic partnerships with vendors and functional leaders to effectively bridge the gap between operational decisions and financial targets. In addition to financial management and modeling, Brenda’s expertise includes strategic planning, operational management and efficiencies, vendor and outsourcing strategies, and federal regulation on aggregate spend. She is a frequent speaker at pharma industry conferences.
Stu Thiede, DrugDev President, Payments – For over six years Stu has led DrugDev’s team of highly skilled and experienced professionals who deliver payment services to clinical trial sponsors and CROs. Under Stu’s direction DrugDev’s Payments business unit has made an unprecedented $2 billion in payments to clinical trial investigators and sites. Stu brings DrugDev customers 30 years of domestic and international expertise in finance, operations, service delivery, and account management in both the technology and pharmaceutical industries, ranging from startups to Fortune 500 companies. His significant international experience includes an assignment in Europe and a finance director role for a Latin American division of Unisys Corporation. For the past 10+ years Stu has been dedicated the pharma industry.
DrugDev recently announced a redesign of its market-leading technology for site payments, processing, reporting and transparency. The upgraded module adds new capabilities and improved usability to deliver a beautiful technology experience for clinical sites and study teams. Click here to watch a 3-minute video on DrugDev’s payments solution. For a complimentary assessment of your current payments process and to schedule a demo of DrugDev’s payments solution, visit drugdev.com/sitepayments.
DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn more at http://www.drugdev.com.
Read the full story at http://www.prweb.com/releases/2016/11/prweb13882168.htm.
Copyright©2016 Vocus, Inc.
All rights reserved